Fidelis Capital Partners LLC Makes New $697,000 Investment in GE HealthCare Technologies Inc. $GEHC

Fidelis Capital Partners LLC purchased a new stake in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) in the 3rd quarter, according to the company in its most recent disclosure with the SEC. The institutional investor purchased 9,276 shares of the company’s stock, valued at approximately $697,000.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Dodge & Cox raised its position in GE HealthCare Technologies by 42.1% in the second quarter. Dodge & Cox now owns 23,567,950 shares of the company’s stock worth $1,745,678,000 after acquiring an additional 6,982,441 shares during the period. Norges Bank bought a new position in GE HealthCare Technologies in the 2nd quarter worth $468,120,000. Holocene Advisors LP lifted its position in GE HealthCare Technologies by 178.5% during the second quarter. Holocene Advisors LP now owns 4,027,352 shares of the company’s stock valued at $298,306,000 after purchasing an additional 2,581,522 shares in the last quarter. Menora Mivtachim Holdings LTD. bought a new stake in GE HealthCare Technologies during the second quarter valued at about $80,755,000. Finally, Balyasny Asset Management L.P. bought a new stake in GE HealthCare Technologies during the second quarter valued at about $58,388,000. Hedge funds and other institutional investors own 82.06% of the company’s stock.

Wall Street Analyst Weigh In

GEHC has been the topic of several recent research reports. Wells Fargo & Company decreased their price objective on GE HealthCare Technologies from $89.00 to $87.00 and set an “overweight” rating on the stock in a research note on Thursday, October 30th. Bank of America increased their target price on shares of GE HealthCare Technologies from $82.00 to $92.00 and gave the stock a “neutral” rating in a report on Monday, January 5th. UBS Group cut shares of GE HealthCare Technologies from a “neutral” rating to a “sell” rating and raised their target price for the stock from $73.00 to $77.00 in a research note on Thursday, January 15th. Citigroup lifted their price target on shares of GE HealthCare Technologies from $83.00 to $88.00 and gave the company a “neutral” rating in a report on Thursday, December 11th. Finally, Barclays initiated coverage on shares of GE HealthCare Technologies in a research note on Monday, October 13th. They issued an “equal weight” rating and a $86.00 price objective for the company. Seven equities research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat.com, the company currently has an average rating of “Hold” and an average price target of $89.83.

GE HealthCare Technologies Price Performance

GEHC stock opened at $78.78 on Friday. The company has a debt-to-equity ratio of 0.83, a quick ratio of 0.95 and a current ratio of 1.18. The company’s fifty day moving average price is $82.58 and its 200-day moving average price is $77.32. GE HealthCare Technologies Inc. has a one year low of $57.65 and a one year high of $94.80. The company has a market capitalization of $35.89 billion, a PE ratio of 16.28, a price-to-earnings-growth ratio of 2.39 and a beta of 1.08.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its earnings results on Wednesday, October 29th. The company reported $1.07 earnings per share for the quarter, beating the consensus estimate of $1.05 by $0.02. The company had revenue of $5.14 billion during the quarter, compared to analysts’ expectations of $5.07 billion. GE HealthCare Technologies had a net margin of 10.94% and a return on equity of 22.52%. GE HealthCare Technologies’s quarterly revenue was up 5.8% on a year-over-year basis. During the same period last year, the company posted $1.14 earnings per share. On average, equities analysts anticipate that GE HealthCare Technologies Inc. will post 4.68 EPS for the current fiscal year.

GE HealthCare Technologies Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, February 13th. Stockholders of record on Friday, January 9th will be given a dividend of $0.035 per share. The ex-dividend date is Friday, January 9th. This represents a $0.14 dividend on an annualized basis and a dividend yield of 0.2%. GE HealthCare Technologies’s dividend payout ratio (DPR) is presently 2.89%.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.